4.3 Article

Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom

期刊

出版社

ELSEVIER
DOI: 10.1016/j.drugpo.2022.103817

关键词

Kratom; Mitragyna speciosa; Mitragynine; Emerging drugs of abuse; Food and drug administration; Federal regulation

资金

  1. Translational Research Institute (TRI) through the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [UL1 TR003107, TL1 TR003109]
  2. UAMS NIDA T32 Addiction Research Training Program [T32 DA022981]
  3. NCATS [KL2 TR003108]

向作者/读者索取更多资源

This study analyzed public perceptions of kratom use and found that kratom is commonly used for various health-related purposes, including mental health, pain management, and substance use disorder. The study also highlighted potential individual-level consequences of using kratom.
Background: The legal status of kratom in the United States is complex and varies by state. The U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration have repeatedly subjected kratom to regulatory review. However, there hasn't been a systematic review of the public's perception of kratom. The present study analyzed open-ended responses from the public to an FDA solicitation for information regarding kratom with the goal of providing a comprehensive assessment of motives for kratom use. Methods: To guide decisions regarding kratom regulation, the FDA solicited comments regarding kratom abuse potential, medical usefulness, and impact of scheduling changes from July through August 2021 and posted them to the Federal Register website. We analyzed comments posted during the first 6 weeks of comment solicitation (6,353) using an inductive approach via qualitative content analysis. Results: Respondents reported 106 independent health-related reasons for kratom use, with most categorized as mental health, pain management, substance use disorder, or miscellaneous purposes that included increasing focus, treating insomnia, and decreasing fatigue. Neurological diseases and digestive disorders were also reported. Relatively few ( < 2%) responses reported recreational use, abuse potential, or adverse effects of kratom. Conclusions: Although kratom is not approved as a safe and effective therapy for any indication, individuals use kratom for a broad spectrum of health-related purposes. Limitations of this study include potential bias for respondents with perceived positive experiences using kratom, lack of demographics data, and lack of independent verification of claims made by respondents. Regardless, this study reflects perceptions regarding the therapeutic uses of kratom and provides insight into potential individual-level consequences of regulating kratom in the U.S. It is important to study the public's perception of kratom use, which can aid regulatory purposes and provide clinically important information on individuals' use and valuation of kratom.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据